KRT18 and metabolic dysfunction-associated steatotic liver disease: CK-18, an inflammatory intermediate filament protein of hepatocytes, is released into the circulation when hepatocyte damage occurs, making it a biomarker of disease progression in NAFLD and liver injury [59].